Company page

Drugs Made In America Acquisition Ii Corp.

Drugs Made In America Acquisition II Corp. (ticker: DMII) is a public company operating in the American market. With a market capitalization of approximately $640.8 million, DMII focuses on opportunities within the pharmaceutical sector. The company aims to contribute to the development and production of drugs made in the United States.

profileDMIIAI content: aiUpdated May 30, 2026/company/drugs-made-in-america-acquisition-ii-corp
Drugs Made In America Acquisition Ii Corp. logo
Ticker
DMII
Market cap
$640.8M
Sector
Finance
Industry
Financial Conglomerates